Ontology highlight
ABSTRACT:
SUBMITTER: Patnaik A
PROVIDER: S-EPMC5501767 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
Patnaik Akash A Swanson Kenneth D KD Csizmadia Eva E Solanki Aniruddh A Landon-Brace Natalie N Gehring Marina P MP Helenius Katja K Olson Brian M BM Pyzer Athalia R AR Wang Lily C LC Elemento Olivier O Novak Jesse J Thornley Thomas B TB Asara John M JM Montaser Laleh L Timmons Joshua J JJ Morgan Todd M TM Wang Yugang Y Levantini Elena E Clohessy John G JG Kelly Kathleen K Pandolfi Pier Paolo PP Rosenblatt Jacalyn M JM Avigan David E DE Ye Huihui H Karp Jeffrey M JM Signoretti Sabina S Balk Steven P SP Cantley Lewis C LC
Cancer discovery 20170308 7
Several kinase inhibitors that target aberrant signaling pathways in tumor cells have been deployed in cancer therapy. However, their impact on the tumor immune microenvironment remains poorly understood. The tyrosine kinase inhibitor cabozantinib showed striking responses in cancer clinical trial patients across several malignancies. Here, we show that cabozantinib rapidly eradicates invasive, poorly differentiated PTEN/p53-deficient murine prostate cancer. This was associated with enhanced rel ...[more]